Drugs / Benserazide/Levodopa
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06976346 | Sep → Oct 2021 | Parkinson disease | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Benserazide/Levodopa | “Benserazide/Levodopa Tablets (Madopar®)” NCT06976346 ↗ |
| Known as | Madopar | “Benserazide/Levodopa Tablets (Madopar®)” NCT06976346 ↗ |